Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65490, first published .
An In-Person and Online Intervention for Parkinson Disease (UPGRADE-PD): Protocol for a Patient-Centered and Culturally Tailored 3-Arm Crossover Trial

An In-Person and Online Intervention for Parkinson Disease (UPGRADE-PD): Protocol for a Patient-Centered and Culturally Tailored 3-Arm Crossover Trial

An In-Person and Online Intervention for Parkinson Disease (UPGRADE-PD): Protocol for a Patient-Centered and Culturally Tailored 3-Arm Crossover Trial

Protocol

1Laboratory of Neuromuscular and Cardiovascular Study of Motion – LANECASM, Department of Physiotherapy, University of West Attica, Athens, Greece

2Department of Health Data Processing, Digital Governance Service, Greek Ministry of Health, Athens, Greece

3Department of Physiotherapy, University of West Attica, Athens, Greece

41st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Corresponding Author:

Michail Elpidoforou, MSc, PT

Laboratory of Neuromuscular and Cardiovascular Study of Motion – LANECASM

Department of Physiotherapy

University of West Attica

Ag. Spyridonos Str.

Egaleo

Athens, 12243

Greece

Phone: 30 6936724706

Email: melpidoforou@uniwa.gr


Background: Dance for Parkinson’s Disease (DfPD) is a dance program for individuals with Parkinson disease (PD). There is a lack of knowledge about the effect of this program on frailty and sarcopenia experienced by patients with PD. In addition, no randomized controlled trial to date has investigated either the possible differential effects of in-person versus online DfPD or the possible effects of DfPD on clinical parameters in Greek patients with PD.

Objective: We aimed to assess the efficacy, safety, and feasibility of a culturally tailored and patient-centered DfPD program offered both in-person and online to Greek patients with early- to midstage PD.

Methods: This is a 3-arm crossover randomized controlled trial (in-person DfPD vs online DfPD vs control) of UPGRADE-PD (Upbeating Greek Application of Dance in Parkinson’s Disease). The experimental period will be 10 months, including three 2-month interventional periods of two 60-minute dance classes per week for each group (in-person DfPD vs online DfPD) versus a control group (nonintervention group), and two 2-month washout periods between each group for 40 Greek patients with early- to midstage PD. Assessments will be performed face-to-face at baseline and at the end of each study period and will include quality of life, fatigue, depressive symptoms, stress, anxiety, sarcopenia, frailty, balance, cognitive functions, movement and nonmovement PD symptoms, and BMI. Safety, feasibility, and patient satisfaction for each dance intervention (in-person DfPD vs online DfPD) will be assessed as well.

Results: The study protocol was approved by the Medical Ethics Committee of the Eginition University Hospital in September 2022 and the Research and Ethics Committee of the University of West Attica in October 2023 and funded in September 2023. The first participant was enrolled in April 2023, and the trial is currently ongoing and will conclude in September 2024.

Conclusions: The results of this study are expected to show the possible differential effect of a patient-centered and culturally tailored in-person vs online DfPD intervention on several movement and nonmovement symptoms, as well as on quality of life, sarcopenia, and frailty in people living with PD in Greece.

Trial Registration: ClinicalTrials.gov NCT06220084; https://clinicaltrials.gov/study/NCT06220084

International Registered Report Identifier (IRRID): DERR1-10.2196/65490

JMIR Res Protoc 2025;14:e65490

doi:10.2196/65490

Keywords



Background

Parkinson disease (PD), an idiopathic, neurodegenerative, and progressive movement disorder, is accompanied by movement and nonmovement symptoms, such as bradykinesia, postural instability, and cognitive and mood disorders, which all negatively affect the quality of life (QoL) [1]. Furthermore, all the aforementioned PD symptoms seem to relate to the reduction of physical activity, muscle mass, and strength levels, as well as movement performance of patients with PD, thus increasing sarcopenia and frailty [2-4]. It is well accepted that systematic physical exercise enhances neuroplasticity [5]; prevents or delays frailty [4,6]; and improves symptoms such as balance, gait, and QoL in people with PD [7].

In dance, the human body and its purposefully selected movements are the basic tools for expression in various rhythmical and cultural contexts, whether artistic, educational, training, recreational, therapeutic, or religious [8,9]. As an art form expressed through movement, dance is a physical activity accompanied by musical stimuli that seems to activate the reward system [1] and has the potential to improve QoL of participants across various age groups [10], while the targeted use of auditory rhythmical information itself seems to be therapeutic for movement and nonmovement symptoms, as well as for QoL, in people with PD [11].

Humans, as social animals, have a fundamental need to belong [12], and dance-based interventions seem to reduce social isolation and loneliness among older people [13], while also facilitating their social inclusion [14], even during the social isolation caused by the COVID-19 pandemic [15]. Positive memories directly connected with dance experiences from a young age, as well as the supportive nature of dance, which enhances social interaction, and the emotional experiences that accompany the dance process, may be some of the reasons older adults prefer dance to other physical activities [16-18].

While physical exercise seems to induce neuroplasticity in people with PD [5], dance has been associated with favorable changes in the corticospinal tract, the corpus callosum, the superior longitudinal fasciculus, the dorsolateral prefrontal cortex, the bilateral putamen, the mirror neuron system, and sensorimotor pathways of healthy dancers [9,19]. Following the aforementioned effects of dance in neuroplasticity, dance in PD seems to enhance psychological flexibility (thus the person tends to adapt to environmental changes more efficiently) and creative self-efficacy (thus the person tends to think creatively and execute these thoughts) [20]. Dance, compared to other types of exercise, improves PD symptoms, such as balance, functional mobility, and cognition [21-24]. Moreover, dance is a substantial motivational means of exercise for patients with PD, enhancing their adherence rates to exercise programs [25,26], as well as a safe, feasible, and enjoyable intervention for patients with early- to midstage PD [27], even when the classes are remotely conducted [28].

Dance for Parkinson’s Disease (DfPD) is a structured dance program under appropriate care and supervision especially designed for people with PD, which integrates different dance genres [29]. Various studies have already described the content of the DfPD class that was followed [30-32]. To our knowledge, there is no published study investigating the effect of DfPD on the frailty and sarcopenia experienced by patients with PD. In addition, no randomized controlled trial to date has been conducted to investigate either the effect of this program on any clinical parameter in Greek patients with PD or the possible differential effect of in-person versus online DfPD. Furthermore, there is no published protocol of any patient-centered or culturally tailored dance intervention for the PD population showing the exact methodology that was followed and the content of the dance intervention. This study aims to fill the above gaps by publishing all the aforementioned data of our research protocol.

Objective

The primary aim of this study is to investigate the possible effectiveness of a patient-centered and culturally tailored dance intervention delivered both in-person (in-person DfPD) and remotely (online DfPD) on QoL of Greek patients with early- to midstage PD. The key secondary aim is to investigate the safety and feasibility of the aforementioned interventions (ie, in-person DfPD and online DfPD) and its possible effectiveness on fatigue, depressive symptoms, stress, anxiety, sarcopenia, frailty, balance, cognitive functions, movement and nonmovement PD symptoms, and BMI of Greek patients with early- to midstage PD.


Study Design

This is a single-centered 3-arm crossover and open-label randomized controlled trial (in-person DfPD vs online DfPD vs control) of UPGRADE-PD (Upbeating Greek Application of Dance in Parkinson’s Disease). Blinding among participants and researchers is not possible due to the nature of the study. There are 6 possible research sequences, as shown in Table 1, and 3 possible carryover effects (1, 2, and 3) for each period from the prior intervention, as shown in Table 2. The study will last 10 months for each participant, including three 2-month research periods and two 2-month washout periods. Assessments will be conducted at enrollment (T−0=week −1), baseline periods (T0=week 0, T2=week 18, and T4=week 36), and postinterventional periods (T1=week 9, T3=week 27, and T5=week 45), as shown in Table 3. Allocation to each of the 6 possible sequences will occur after the completion of the first baseline assessment, as shown in the participant flow in Figure 1.

Table 1. The UPGRADE-PD (Upbeating Greek Application of Dance in Parkinson’s Disease) study design.
SequencePeriod

FirstSecondThird
ABCAaBbCc
BCABCA
CABCAB
ACBACB
BACBAC
CBACBA

aIntervention A (in-person Dance for Parkinson’s Disease combined with usual medical care).

bIntervention B (online Dance for Parkinson’s Disease combined with usual medical care).

cControl group (usual medical care without Dance for Parkinson’s Disease).

Table 2. The UPGRADE-PD (Upbeating Greek Application of Dance in Parkinson’s Disease) study’s code for the possible carryover effect.
SequenceFirst periodSecond periodThird period

TrialCarryover effectTrialCarryover effectTrialCarryover effect
ABCAa0bBc1dCe2f
BCAB0C2A3g
CABC0A3B1
ACBA0C1B3
BACB0A2C1
CBAC0B3A2

aIntervention A (in-person Dance for Parkinson’s Disease combined with usual medical care).

bNoneffect.

cIntervention B (online Dance for Parkinson’s Disease combined with usual medical care).

dEffect from intervention A.

eControl group (usual medical care without Dance for Parkinson’s Disease).

fEffect from intervention B.

gEffect from the control group.

Table 3. The UPGRADE-PD (Upbeating Greek Application of Dance in Parkinson’s Disease) schedule of enrollment, interventions, and assessments for participants.
Time point (wk)Study period

Enrollment (T–0=wk –1)Baseline 1 (T0 =wk 0)Allocation (T0 =wk 0)Postintervention 1 (T1 =wk 9)Wash-out 1 (T1 =wk 9)Baseline 2 (T2 =wk 18)Postintervention 2 (T3 =wk 27)Wash-out 2 (T3 =wk 27)Baseline 3 (T4 =wk 36)Postintervention 3 (T5 =wk 45)
Enrollment

Eligibility screen









Informed consent









Allocation








Interventions

In-person DfPDa

AbBc






Online DfPD




AB



Control group







AB

Wash-out



AB
AB
Assessments

SDd and MHe









AEf and SAEg









Adherence rates









Attrition rates









Recruitment rates









Patient satisfaction









PDQ-8h




PFS-16i




MFISj




DASS-21k




SARC-Fl




EWGSOP2m




FPn




BBSo




MoCAp




MDS-UPDRSq




BMI




Music preferences








aDfPD: Dance for Parkinson’s Disease.

bA: starting point of the period.

cB: ending point of the period.

dSD: sociodemographics.

eMH: medical history.

fAE: adverse event.

gSAE: serious adverse event.

hPDQ-8: Parkinson’s Disease Questionnaire-8.

iPFS-16: Parkinson Fatigue Scale-16.

jMFIS: Modified Fatigue Impact Scale.

kDASS-21: Depression, Anxiety, and Stress Scale-21.

lSARC-F: Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls Scale.

mEWGSOP2: European Working Group on Sarcopenia in Older People.

nFP: Frailty Phenotype.

oBBS: Berg Balance Scale.

pMoCA: Montreal Cognitive Assessment.

qMDS-UPDRS: Movement Disorder Society–sponsored revision of the Unified Parkinson’s Disease Rating Scale.

Figure 1. Flow diagram of the study.

Study Setting

We aim at examining whether following a twice per week DfPD class in-person or remotely for 8 weeks improves the study clinical parameters compared to usual care alone. A total of 40 patients with early- to midstage PD have been randomized to undergo a total of sixteen 60-minute DfPD classes twice weekly for more than 8 weeks, both in-person and online. The study will be conducted following the ethical principles of the Declaration of Helsinki and its later amendments [33], and the Pre-emptive Pharmacogenomic Testing for Preventing Adverse Drug Reactions (PREPARE) trial guide [34], and will conform with the CONSORT (Consolidated Standards of Reporting Trials) guidelines for randomized crossover trials [35], as shown in Figure 1, and the Standard Protocol Items Recommendations for Interventional Trials (SPIRIT) [36-38]. Eginition University Hospital Neurological Outpatient PD Clinic is the participating center, and the first participant was enrolled in April 2023.

Ethical Considerations

The study protocol was approved by the Medical Ethics Committee of the Eginition University Hospital (approval 688/07.09.2022) and the Research and Ethics Committee of the University of West Attica (approval 92282/10/10/2023) and registered at ClinicalTrials.gov (NCT06220084). Written informed consent will be obtained from all participants. At the time of manuscript submission, recruitment has been concluded, but the trial is ongoing.

Eligibility Criteria

The inclusion criteria for patients were set as follows: (1) age ≥18 years; (2) established diagnosis of idiopathic early to moderate PD, from 0 to 2.5 according to Hoehn and Yahr stages [39]; (3) being patient of the Eginition University Hospital Neurological Outpatient PD Clinic and under a stable medication for ≥4 weeks; (4) absence of other comorbidities or conditions that seriously affect or may affect mobility (eg, musculoskeletal or cardiovascular issues, pregnancy, terminal illnesses—such as cancer) according to attending physician’s discretion; (5) ability to understand, write, and speak in Greek; (6) written consent for participating in the study; (7) a consent of attending physician for participating in an exercise program, given they are totally aware of the patient’s clinical and physical status and medications; (8) smart device (either smartphone or tablet, laptop, or computer) access for the dance intervention that will be conducted remotely; (9) absence of serious cognitive impairment, according to attending physician’s discretion.

The exclusion criteria for patients were set as follows: (1) a non-PD tremor disorder diagnosis; (2) moderate to severe PD (≥3 Hoehn and Yahr stages) [39] because of a high fall risk [40]; (3) serious health or disability issues (either physical or mental, including pregnancy), because of which exercise is not permitted or exercise instructions cannot be followed; (4) hearing issues for which patient cannot follow music or verbal guidance; (5) non-PD related mental or mobility disorder; (6) any electronic internal medical device or implant, such as a pacemaker or a deep brain stimulation, due to contraindication in the use of bio-electrical impedance analysis [41]; (7) no access of the participant or patient’s carer to any smart device (either smart phone or tablet, laptop, or computer).

Interventions

Explanation for the Choice of Comparators

The COVID-19 pandemic placed significant restrictions on the social circulation and exercise of patients with PD and highlighted the necessity of finding alternative forms of therapeutic exercise, such as telerehabilitation [42,43]. The use of telerehabilitation in neurological diseases is constantly expanding [44]. Online attendance in therapeutic dance classes for patients with PD is feasible and safe and is characterized by high compliance rates; it enables training of participants in new technologies and it is easy, fast, and inexpensive [27,28]. While we have already presented evidence that in-person DfPD is safe, feasible, and potentially effective in improving several movement and nonmovement symptoms of Greek patients with PD [45], there are no data regarding a related study conducted online.

Intervention Description

A total of sixteen 60-minute DfPD classes will be conducted twice weekly for 8 weeks, both in-person and online, in a physiotherapy facility in Athens, Greece (in-person DfPD), and via Zoom platform (online DfPD; Zoom Communications, Inc), which will be free for the participants; the facility is licensed for the establishment and operation of physiotherapy activities. All the dance classes will be instructed by the main investigator (ME), who holds the approval to use DfPD for research reasons and is a licensed neurological physiotherapist, adapted physical educator, and dance educator. The exact structure and content of the program are described in Table 4. Participants will be instructed individually on how to use the Zoom platform before their program entry. Frequency and duration of the program are in accordance with past exercise and dance programs in patients with PD [30,45-48].

Table 4. UPGRADE-PD (Upbeating Greek Application of Dance in Parkinson’s Disease) study’s DfPD structure and content.
Part (category) and track numberType of activityType of exercisePrimal goalsSong title, album title (release date), composer
1 (seated warm-up)

1Introduction: “The Sun Salutation”Breathing exercises and gradual early mobilizationGeneral warm-up, increase of concentration, and general mobilization“Love in the Heart” (remastered 2004), 30 Nocturnes (1987), Manos Hadjidakis

2Introduction to flow: legatoGradual moderate intensity and limp and torso mobilizationSpecific warm-up and introduction to contemporary dance“By the Sea,” Eternity and a Day (1998), Eleni Karaindrou

3Storytelling: “The Outside the Window Travel”Introduction to spine twist movements and arm wavesAesthetics, fantasy stimulation, and visualization“The Young Rallou” (remastered 2004), 30 Nocturnes (1987), Manos Hadjidakis

4Introduction to upper limb velocity: staccatoTapping movements, rotational arm movements, gestures, and visual contactCoordination, diadochokinesia, and group dynamics“The River,” The River (1959), Manos Hadjidakis

5Story telling: “The Ocean Dive”Torso and upper extremities “waving”Fantasy and imagination stimulation and visualization, successive movement“Two,” Two (2006), Konstantinos Vita

6Limb and torso mobilization“Flex point”Coordination and seated posture“Who Pays the Ferryman,” Who Pays the Ferryman (1977), Yannis Markopoulos

7Storytelling: “High Five”Arm waves, stretch side to side, high five in pairs interaction, and spine rotationSocial interaction, spine mobilization, and group dynamics“When the Clouds Come,” Gioconda’s Smile (1965), Manos Hadjidakis

8Introduction to velocity: staccatoRhythmical walking on the spot and transition of weightRhythm, speed switching, and coordination“Rain,” Gioconda’s Smile (1965), Manos Hadjidakis

9Storytelling: “Opa”Staccato-and-legato body movementsSocial interaction, speed switching, and movement dynamics (staccato-legato transitions)“I Hartaetoi” (remastered), I Gitonia Ton Aggelon (2004), Mikis Theodorakis
2 (supported by chairs—standing position)

10Ballet barre exercises“Pliés relevés” in 1st and 2nd foot position, coordinated arms and legs movements, and “port de bras” movementsIntroduction to basic ballet steps, balance, coordination, and postureMovement 9, Mythodea—Nocturne (2019), Vangelis Papathanasiou (Vangelis)

11Introduction to the standing coordinated movementTransition of weight side to side, on-spot walking, coordinated limb movementsCoordination, rhythm, and balance“Kemal (O Mithos Tou Sevah),” 30 Nocturnes (1987), Manos Hadjidakis

12“Sirtaki”Transition of weight side to side, on-spot runningIntroduction to basic sirtaki steps, coordination, balance, and stamina“The Original Sirtaki Zorbas,” Zorba the Greek 1964, Mikis Theodorakis
3 (nonsupported standing position)

13“Zeibekiko”Forward-backward-side transfer of weight, turns, and free improvisationRhythm, creativity, and introduction to basic zeibekiko steps“Evdokia’s Zeibekiko,” Evdokia (1972), Manos Loizos

14“La Révérence”: the goodbye sectionMovement in a circle and one-leg balance positions with open and closed eyesBalance, group dynamics, cooldown, and finish of the class“A Stroll to the Moon,” 30 Nocturnes (1987), Manos Hadjidakis
Strategies for Improved Adherence to Interventions

Although it has already been shown that dance interventions have higher adherence rates and lower attrition rates than other types of exercise in people with PD [49,50], we have implemented several actions within a more patient-centered and culturally tailored approach, as described in subsequent sections, to further increase patient continued participation.

Patient-Centered Dance Therapeutic Intervention

During the last decades, biomechanical-based therapeutic models in physiotherapy [51,52] have been progressively replaced by more “embodied” therapeutic approaches, in which each diversity and difference is accepted in a more inclusive attitude, which considers patient’s bodily and movement image [53]. This approach can be seen as part of a more personalized patient-centered physiotherapeutic approach, which is considered as a practical application of the biopsychosocial model [54,55] in terms of integrating the “patient world” in a comprehensive, empathic, and individualized tailored approach [56], and has been already used by physiotherapists, as a more holistic therapeutic approach in neurological patients [57]. The above model takes into serious consideration patients’ preferences, needs, and values [58], while it seems to enhance power, responsibility, and therapeutic alliance [59], and relates to better outcomes and QoL in patients with PD [60].

As there are many models and conceptualizations around patient-centeredness in physiotherapy [61], we proposed an 8-number domain of patient-centeredness in therapeutic dance interventions for PD patients with PD (Textbox 1, adapted from the studies by Stewart [55], Brown et al [62], Little et al [63], Stewart [64], Langendoen [56], Dukhu et al [65], and van der Eijk et al [58]), which was adapted from the patient-centeredness approach in medicine [55,62-64], the aspects of patient-centeredness in physiotherapy [56], the person-centered physiotherapeutic management of long-term conditions [65], and the patient-centered health care aspects for patients with PD [58].

The procedures that will be performed during our study according to this proposal are outlined in Textbox 2.

Textbox 1. Domains of patient-centeredness in therapeutic dance interventions for patients with Parkinson disease.
  1. A multidimensional and empathic assessment by a trained therapeutic dance health care professional with experience in Parkinson disease for a holistic understanding of the patients’ issues, concerns, preferences, and need for tailored information
  2. A comprehensive planning and explaining of the physical assessment and the therapist’s hypotheses
  3. Mutual agreement between patient and therapist on the multidimensional characteristics of the patient’s tailored issue after a holistic and valid assessment and interdisciplinary scientific collaboration
  4. Mutual agreement between patient and therapist on the therapeutic intervention’s goals
  5. Building of a high-confidence environment, accompanied by emotional support, empathy, and respect, between patient and therapist for enhancing the patient’s levels of self-responsibility, self-management, and independence
  6. Treatment adaptations and modifications during possible circumstances differentiation
  7. Individualization of exercises, dance combinations and techniques, and teaching methods
  8. Sufficient and realistic use of resources and time and continuous health care accessibility
Textbox 2. Procedures that will be performed during the study.
  1. The assessment is structured, for research reasons; it is characterized by empathy, and includes multiple movement and nonmovement aspects of Parkinson disease (PD), giving a full informative description of the study’s procedures and goals to participants by the main researcher (ME), who is a specialized neurological diseases physiotherapist, and an adapted physical and dance educator. Although ME is responsible for the whole communication with patients, assessments before and after each research period will be performed by an independent researcher who is specialist in the use of the specific tools to eliminate possible detection bias. Part of the assessment (Movement Disorder Society–sponsored revision of the Unified Parkinson’s Disease Rating Scale [MDS-UPDRS] and Montreal Cognitive Assessment [MoCA] tests) will be performed by specialized neurologists of the Eginition Neurological Outpatient Clinic (domains 1 and 3).
  2. Each step of the assessment procedure before and after each research period is explained; the necessity that each patient gives continuous feedback about possible adverse events is emphasized (domain 2).
  3. Translated and validated scientific tools are used, and a continuous multidisciplinary scientific collaboration between physicians, nurses, and physiotherapists is ensured as part of this study (domain 3).
  4. Therapeutic intervention goals were based on past research; however, personal patient needs were adapted in the dance combination’s design, based on our past pilot study [45], while individual music preferences were considered for the dance intervention’s design [66] (domain 4).
  5. A high-confidence environment, accompanied by emotional support, empathy, and respect between participants and the physiotherapist, will be ensured (domain 5).
  6. Although the early- to midstage severity stage of PD of participants usually does not demand specific modifications for each participant, due to the related motor independence with low fall risk [40], we are prepared to adapt our dance intervention following possible individual circumstances (domain 6).
  7. Dance for Parkinson’s Disease (DfPD) classes are generally characterized by supportive instruction in a way that participants feel free to perform each dance combination in their individual level of functionality [67]; thus, inclusion, adaptability, and accessibility to all are promoted during each dance class [68] (domain 7).
  8. The dance intervention is being conducted in a facility that is offered for free. Classes will be conducted solely by the main researcher (ME), while the trial will be partially funded by a charitable association, and continuous accessibility of patients to the research team will be provided (domain 8).
Culturally Tailored Therapeutic Dance Intervention

Most nation states were created during the 19th century, when cultural elements were used as potent symbols to serve each national identity [69], such as music and dance [70]. Dance has been used as a powerful tool in the creation of national identity [71] and as a national symbol that seems to emotionally empower members of a community [72]. Particularly in Greece, events involving dance are used for entertainment, socializing, and escape from everyday routine, as well as a sign of well-being that underpins the Greek national identity [73,74].

Dance is a physical activity in which the basic tool is the human body and its purposefully selected movements in a potentially varied rhythmical and cultural context [8]. Dance can be defined as ethnic, where movement types and motivation agree with the way of life and socially accepted norms of a period, and theatrical, where movement patterns are consciously designed to be shown to an audience that is not necessarily familiar with its context [75], even considering that every dance in any context contains ethnic elements [76]. Each person, even unconsciously, dances, bringing to bear all their past intra- and interpersonal experiences and cultural values within the specific socioeconomical environment they live [77], we decided to examine the effect of our dance intervention practice taking into consideration the cultural background of the targeted individuals, who in our case were Greek patients with PD.

DfPD is a dance intervention specially designed for patients with PD, which integrates different dance genres, encourages dance exploration, and focuses on dancing individually and in groups rather than in pairs [45]. For culturally adjusting this intervention to our population, we proceeded with several actions, as noted subsequently. First, we adopted the term “culturally tailored,” instead of “culturally adjusted,” as it has been already proposed in past research and it refers to the total sum of adaptations that must be done in terms of content, symbolisms, and strategies in an intervention to best suit specific cultural characteristics, and thus positively affect health behavior and cultural expression [78].

To incorporate Greek culture elements into our dance intervention, we focused on both surface structure (culturally matched music and dance movements or steps) and deep structure (social and historical influences) as prerequisites for feasibility and efficacy or impact of the dance intervention accordingly [79]. Although collecting participant needs and experiences through exploratory focus groups may better inform both the surface and deep structure of the intervention [79], we based our intervention on past research and participants’ music preferences [66], as described subsequently, to reduce the cost and duration of the study (domain 8, Textbox 1).

All the 14 selected music pieces were composed by Greek artists, and they have been chosen for their capability to serve the idea of Greekness or “Hellinikotita” and being well known in most of the Greek population. While Greek folk dances can be used as a therapeutic tool for older adults at risk of neurodegeneration [80], and they seem to improve functional and psychological characteristics leading to better outcomes in terms of QoL in patients with chronic diseases [81], 2 of the earlier mentioned dances (tracks 12 and 13) were selected for the aforementioned reasons. Furthermore, they seem to have several semiotic cultural references; thus, they may involve symbolic signals for the Greek population [82,83]. The explanation for each music selection is noted below (Table 5).

Table 5. Explanation for each musical selection in terms of cultural tailoring.
TracksComposerExplanation for each music selection
1, 3, 4, 7, 8, 11, and 14Manos HadjidakisManos Hadjidakis was a well-known Oscar-winning Greek composer whose work led to the development of a musical language combining popular musical elements directly connected with the Greek cultural memory [84].
9, 12Mikis TheodorakisMikis Theodorakis’ work, along with that of Hadjidakis, influenced the idea of Greekness or “Hellinikotita” in the music of the 20th century, while he was characterized by his political influence on late 20th century in Greece [85]. Especially, the 12th track refers to the internationally well-known Greek folk dance “syrtaki,” which has been the most famous Greek melody since its birth in 1964, and as part of the film “Zorba the Greek” has been included as a musical semiosis to the Greek cultural identity [82,86].
2Eleni KaraindrouEleni Karaindrou is a Greek artist established for her works in the cinema [87]. The music piece has been chosen from the film Eternity and a Day by Theo Angelopoulos, a movie that influenced Greek filmography of the past century and managed in an artistically abstract way to reconstruct the history of Greece, the Balkans, and Europe in a context full of historical and political allegories [88].
13Manos LoizosThis track refers to the most well-known music that accompanies the “zeibekiko” dance (“Evdokia’s Zeibekiko”), a mostly improvisational Greek folk dance directly connected with “rebetiko” culture, and which, from 1980 onwards, has been defined as a pan-Hellenic semiotic dance, leading someone to nonverbally express their emotions [83].
6Yannis MarkopoulosYannis Markopoulos is an internationally well-known Greek composer. The selected musical piece was composed for the British Broadcasting Corporation (BBC) television series “Who Pays the Ferryman?” a drama series with great success in Great Britain, Europe, Canada, and Australia [89].
5Konstantinos Vita (known as K.BHTA)K.BHTA is the founder of the well-known Stereo Nova Greek electronic music band (1992-1996), while the selected music piece was produced to accompany the dance performance 2 of Dimitris Papaioannou (2006), an internationally well-known Greek choreographer, and artistic director of the opening and closing ceremonies of the 2004 Athens Summer Olympic Games.
10Evangelos Odysseas Papathanassiou or Vangelis Papathanasiou (known as Vangelis)Vangelis was a well-known Oscar-winning Greek composer, and the selected music piece is part of the internationally well-known music album Mythodea—Music for the NASA Mission: 2001 Mars Odyssey.
Music Preferences

People seem to develop musical identities from an early age in the context of constructing a more general self-identity [90], either as individuals (personal identity) or as members of larger social groups (social identity) [91,92]. Music preferences play a key role in both personal and social parameters of self-identity by participating in the construction of (1) self-image, (2) self-definition, (3) sense of belonging and acceptance by a certain social group, and (4) specific personal values’ reflection [66].

In the “musical preferences” scale by Gardikiotis and Baltzis [66], 24 music genres are included on a 6-point scale (0=I do not know this music genre and 1=I do not like it at all, to 5=I like it very much) [93], and divided into 5 factors: (1) “sentimental and sensational,” (2) “sophisticated and complex,” (3) “nonmainstream dissonant,” (4) “established rebellious,” and (5) “native-Greek traditional.”

During the enrollment phase (Table 3), music preferences of all the participants were registered, and taking in serious consideration the strong music preference frequency (“I like it very much”) of most participants (>50%), we compiled the list of selected music titles of the intervention (Table 4). As it is shown in Table 6, the first 4 categories of strong music preferences frequency were formed by music genres of the “established rebellious,” which includes Greek art popular (entechno), and “native Greek traditional” scale’s factors, which includes rebetika, laika (Greek urban popular), and Greek folk (traditional) music.

Table 6. Strong music preference frequency (“I like it very much”) based on a 6-point scale.
Music genreFrequency “I like it very much,” n (%)
Greek art-popular (entechno)24 (60)
Greek urban-popular (laika)24 (60)
Rebetika24 (60)
Greek folk (traditional)23 (57.5)
Classical19 (47.5)
Greek rock18 (45)
Greek pop18 (45)
Pop (contemporary and Western-style)18 (45)
Jazz18 (45)
Rock ‘n’ roll18 (45)
Blues17 (42.5)
Greek laika pop14 (35)
Rock14 (35)
World (ethnic) music13 (32.5)
Reggae9 (22.5)
Soul or rhythm and blues8 (20)
Hard rock or metal6 (15)
Greek rap or hip-hop4 (10)
Rap or hip-hop3 (7.5)
Funk3 (7.5)
Punk3 (7.5)
House3 (7.5)
Alternative2 (5)
Trance1 (2.5)
Criteria for Discontinuing or Modifying Allocated Interventions

Participants are free to withdraw from the study at any time and for any reason. As it has been previously mentioned, according to the patient-centered approach that we follow, we have been prepared to adapt our dance intervention following possible differentiation in circumstances (domain 6, Textbox 1). DfPD classes are generally characterized by supportive instruction in a way that participants feel free to perform each dance combination at their individual level of functionality [67]; thus, any personal modification or interpretation is always encouraged to be performed by each participant (domain 7, Textbox 1).

Outcomes

Primary Outcomes

Patients’ QoL before and after each research period will be assessed by the change in total score of the Greek version [94] of Parkinson’s Disease Questionnaire-8 [95], which is a 0-to-100-point scale with a higher score indicating worse QoL.

Key Secondary Outcomes

The expected key secondary outcomes are outlined in Textbox 3.

Textbox 3. Key secondary outcomes.

Safety (occurrence of adverse events and serious adverse events)

The occurrence of adverse events such as possible falls, injuries, muscle soreness, and excessive fatigue [96] will be assessed by recording after the end of the program, as has been done in our past pilot clinical study [45], for each participant. The following are considered as serious adverse events [96,97], and they will be recorded after the end of the program: death, threat to life, hospitalization, persistent or significant disability or incapacity, and necessity of surgical operation for any of the aforementioned events.

Feasibility

Adherence rates: an adherence rate of ≥70% is considered as high in older patients with functional limitations [98], and it will be used to assess adherence to each dance intervention following the appropriate formula after the end of the program:

Attrition rates: an attrition rate of ≤15% is considered as acceptable by the Physiotherapy Evidence Database Scale [99], and will be used to assess attrition to each dance intervention following the appropriate formula after the end of the program:

Recruitment rates: for the assessment of the recruitment rates, a target of up to 5 months for 40 participants will be accepted according to past studies [45,100] after the end of the program.

Patient satisfaction

Willingness to continue the program after the intervention: a verbal statement for continuing the program after the end of the intervention in a 6-point Likert scale (0=I don’t know if I’d like to continue the program, 1=I don’t want to continue the program at all, 2=I don’t want to continue the program, 3=I might want to continue the program, 4=I want to continue the program, and 5=I want to continue the program very much) after the end of the program.

Advantages and disadvantages of the program: there will be a total of 2 open questions: (1) Could you please list all the positive and negative points of the in-person Dance for Parkinson’s Disease (DfPD) intervention? and (2) Could you please list all the positive and negative points of the online DfPD intervention? These will be asked in a one-to-one interview of each participant by the principal investigator (ME) after the end of the program for the qualitative recording of advantages and disadvantages of each dance intervention from the patient’s perspective.

Secondary Outcomes

The other expected secondary outcomes are outlined in Textbox 4.

Textbox 4. Other secondary outcomes.

Fatigue

  • Parkinson Fatigue Scale-16 (PFS-16): fatigue will be assessed before and after each research period by the change in total score of the Greek version [101] of PFS-16 [102], which is a 1- to 5-point scale with a higher score indicating more fatigue.
  • Modified Fatigue Impact Scale: fatigue will be also assessed before and after each period by the change in total score of the Greek version [103] of the Modified Fatigue Impact Scale [104], which is validated in the population with Parkinson disease (PD) [105] 0- to 84-point scale, with a higher score indicating more fatigue.

Depressive symptoms

  • Depressive symptoms will be assessed before and after each research period by the change in total score of the Greek version [106,107] of the depression subscale score of Depression, Anxiety, and Stress Scale-21 (DASS-21) [108], which is a validated in the population with PD [109] 0-to-42-point scale with 0 to 9 indicating no symptomatology, 10 to 12 indicating mild symptomatology, 13 to 20 indicating moderate symptomatology, 21 to 27 severe symptomatology, and 28 to 42 extremely severe symptomatology.

Stress

  • Stress will be assessed before and after each research period by the change in total score of the Greek version [106,107] of the stress subscale score of DASS-21 [108], which is validated in the population with PD [109] 0-to-42-point scale, with 0 to 10 indicating no stress, 11 to 18 indicating mild stress, 19 to 26 indicating moderate stress, 27 to 34 severe stress, and 35 to 42 extremely severe stress.

Anxiety

  • Anxiety will be assessed before and after each research period by the change in total score of the Greek version [106,107] of the anxiety subscale score of DASS-21 [108], which is validated in the population with PD [109] 0- to 42-point scale, with 0 to 6 indicating no anxiety, 7 to 9 indicating mild anxiety, 10 to 14 indicating moderate anxiety, 15 to 19 severe anxiety, and 20 to 42 extremely severe anxiety.

Sarcopenia

  • Sarcopenia risk will be assessed before and after each research period by the change of total score of the Greek version [110] of Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls Scale [111], which is a 0 to 10 self-reporting screening tool of five 0- to 2-point components (strength, assistance walking, rise from a chair, climb stairs, and number of falls) with 0 to 3 indicating no risk for sarcopenia, and ≥4 indicating risk of sarcopenia.
  • Sarcopenia status will be assessed before and after each research period by the change of European Working Group on Sarcopenia in Older People criteria [112], as has been previously assessed in the PD population [113]. According to the European Working Group on Sarcopenia in Older People, sarcopenia is (1) probable in an individual with low muscle strength (hand grip strength [HGS] for men: <27 kg and women: <16 kg), (2) confirmed in an individual with the above criteria combined with low muscle quantity (appendicular skeletal muscle mass index for men: <7 kg/m2 and women: <5.5 kg/m2), and (3) severe in an individual with the 2 above criteria combined with low physical performance (4 m usual walking speed test≤0.8 m/s). HGS will be assessed by a calibrated digital handheld dynamometer, appendicular skeletal muscle mass index by a bioelectrical impedance analysis equipment, and physical performance by the4-m usual walking speed test.

Frailty

  • Frailty will be assessed before and after each research period according to the most often used frailty scale in PD [4] frailty phenotype (FP) status [114], in which 5 criteria have to be assessed: (1) unintentional weight loss >5 kg the last year, (2) weakness (HSG for men: <27 kg and women: <16 kg), (3) slow walking speed (10-m usual walking speed test ≤0.8 m/s), (4) exhaustion (PFS-16 total score ≥3, which indicates moderate to severe fatigue), and low levels of physical activity (a total score <600 MET/min/week-1 indicates inactivity in the Greek version of International Physical Activity Questionnaire-Short Form [115]). The FP score ranges from 0 to 5 (1 point for each criterion; 0: best score to 5: worst score), and defines as frail an individual with a score of ≥3, as prefrail an individual with a score of 1 to 2, and as nonfrail or robust an individual with a score of 0.

Balance

  • Balance will be assessed before and after each research period by the Greek version [116] of Berg Balance Scale [117], which is a 14-item validated in PD [118] scale with a minimum score of 0, and a maximum score of 56, while lower scores indicate worse balance (0-20: high fall risk, 21-40: medium fall risk, and 41-56: low fall risk).

Cognitive functions

  • Cognition will be assessed before and after each research period by the Greek version [119,120] of Montreal Cognitive Assessment (MoCA) [121], which is a 0- to 30-point scale with lower scores indicating cognitive impairment.

Movement and nonmovement PD symptoms

  • Movement and nonmovement PD symptoms will be assessed before and after each research period by the Greek version of Movement Disorder Society–sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) [122], which is a 4 parts scale. Part I assesses nonmotor experiences of daily living (13 items, score range: 0-52), part II assesses motor experiences of daily living (13 items, score ranges: 0-52), part III assesses motor signs (33 items, score ranges: 0-132), and part IV assesses motor complications, namely dyskinesias and motor fluctuations (6 items, score ranges: 0-24). Each item score ranges from 0 (normal) to 4 (severe), and higher scores indicate a greater impact of PD signs.

BMI

  • BMI will be assessed before and after each research period by the score from the equation kg/m2, with <18,5 indicating underweight, 18.5 to 24.9 indicating normal weight, 25 to 29.9 indicating overweight, and ≥30 indicating obesity (3 obesity subcategories exist: Class I scores of 30-34, Class II scores of 35-39, and Class III scores of ≥40) [123].

Sample Size

A prospective, nonrandomized, uncontrolled, open-label pilot study has already been conducted in a Greek population of 16 patients with early- to midstage PD, showing that in-person DfPD is safe and feasible, and can improve QoL, as well as several movement and nonmovement PD symptoms [45]. According to the results of the above pilot clinical trial for our primary outcome (QoL), the Cohen equations for sample size calculation [124], and considering the power of the study equal to 80% and the level of statistical significance of the controls equal to the conventional limit of statistical significance (α=.05), a power analysis was applied with the a priori formula for the F test statistical control through analysis of variance with repeated measures using G*Power software (version 3.1) [125].

Taking in consideration that the number of experimental groups will be 3, the number of repeated measurements for each participant will be 6, and the average correlation coefficient between repeated measurements will be 0.64, it was estimated that for this study, which has a 1:1:1:1:1:1 distribution ratio of participants to the groups, at least 6 participants are required in each group (18 in total). On the basis of the equations that adjust the sample size to the expected dropout rate [126], which is expected to be up to the 15% acceptable value, based on the Physiotherapy Evidence Database Scale [99], the minimum sample size required to achieve the study’s primary end point (QoL) is 21 participants.

Recruitment

Recruitment started 6 months before the starting date of the program via relevant printed information material and health care practitioners (neurologists and nurses) of the Eginition University Hospital Neurological Outpatient Clinic. All study procedures have been discussed face-to-face individually with each potential participant before screening for eligibility by the primary researcher. The primary researcher (ME) has obtained written informed consent from the potential clinical trial participants before the study’s inclusion.

Assignment of Interventions: Allocation

A block randomization will be conducted after the completion of the first baseline assessment (Figure 1) in equal ratio (1:1:1:1:1:1) to 1 of the 6 study sequences (ABC, BCA, CAB, ACB, BAC, or CBA), as further shown in Table 1 [127]. Concealment is ensured by keeping study material in sealed, opaque envelopes and by using paper assignment. After baseline 1 assessment completion (Figure 1), each participant will be randomized to 1 of the 6 study sequences by the data analyst, and the document with the final groups’ formation will be delivered in a sealed envelope to the principal investigator, who is the responsible for participants’ enrollment.

Data Collection and Management

All assessments will be conducted face-to-face by an independent investigator to eliminate possible detection bias, except of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale and Montreal Cognitive Assessment, which will be conducted face-to-face by specialized neurologists of the Eginition University Hospital Neurological Outpatient Clinic.

Participants are free to quit at any time if they wish to discontinue the study. In that case, reasons for withdrawal will be recorded, if this is possible. Participant’s enrollment will be followed by the research team’s assistance during the entire study period, including scheduling of data collection appointments, reminding of intervention’s appointments, and communicating the starting time of each research period.

Data, including consent forms, completed paper-based data files, and study notes, will be securely stored in the main investigator’s office, which will be locked. Raw data will be encrypted and stored digitally on a local computer with access rights to the main investigator. All original data will be archived for 5 years after the completion of the research and then destroyed, according to local regulations. All written data will be stored in a locked cabinet of the main investigator’s locked office for 5 years and then destroyed. Digital data will be stored on a password-protected local computer.

Statistical Analysis

The primary analysis will evaluate the between group differences in total score of the Greek version of Parkinson’s Disease Questionnaire-8 after each research period. Mean (SD) or summary statistics appropriate to the distribution of the QoL total score will be reported by study group (in-person DfPD vs online DfPD vs control). Study groups will be compared in terms of QoL using mixed model repeated measures considering the correlated data from the same patient [128]. Mixed model repeated measures are robust in small sample size studies; thus, a decreased risk of type II errors occurs [129]. For all secondary end points, summary statistics will be tabulated by study group, and study groups will be compared with a statistical method appropriate to the type of the end point (eg, continuous and categorical end point). Bonferroni correction will be used to account for multiple comparisons of secondary outcomes.

A secondary analysis of the primary end point will adjust for those prerandomization variables which might reasonably be expected to be predictive of favorable QoL total score. Any deviations from the protocol will be recorded and agreed by the investigators. Missing data will not be imputed neither for primary nor secondary analyses, and no interim analyses will be conducted in this study. All the P values are 2-sided at an α level of .05. Analyses will be conducted with SPSS (version 20.0; IBM Corp) and R (version 4.4.1; R Foundation for Statistical Computing).


The study is a 3-arm crossover and open-label randomized controlled trial (in-person DfPD vs online DfPD vs control), and was partially funded in September 2023. The first participant was enrolled in April 2023. The trial is currently ongoing, and will conclude in September 2024. A total of 47 patients were enrolled during the recruitment period, of whom 7 have been excluded (Figure 1). A total of 40 patients were randomized equally to the study’s 6 sequences to undergo sixteen 60-minute culturally tailored DfPD classes both in-person and online during a 10-month experimental period following a patient-centered approach. The data analyst will analyze all the data after the final participant exists the study. We expect that by the second quarter of 2025, the study’s results will have been published.


Principal Findings

This is a 3-arm crossover and open-label randomized controlled trial (in-person DfPD vs online DfPD vs control), which aims to evaluate the efficacy, safety, and feasibility of a patient-centered and culturally tailored DfPD intervention delivered both in-person and online as a complementary therapy for a series of movement and nonmovement PD symptoms, as well as for QoL, sarcopenia, and frailty of Greek patients with PD.

Frailty is a state most common in older people, characterized by high vulnerability to acute stressors, such as falls, which are associated with increased hospitalization and mortality risk as well as disease severity or progress [130]. Patients with PD, accompanied by sarcopenia and frailty, seem to have lower cognitive function, movement performance, and QoL; recurrent falls; and higher fatigue, orthostatic hypotension, and inpatient mortality. Physical exercise programs seem to reduce or prevent the risk of both conditions; thus, they may improve the QoL of patients with PD [2,4,6,131]. The possible effect of DfPD on sarcopenia and frailty of Greek patients with early-to-midstage PD has not been examined. Furthermore, there is no controlled study investigating any possible differential effect of in-person and remote delivery of the aforementioned program on the QoL of patients with PD, fatigue, depressive symptoms, stress, anxiety, sarcopenia, frailty, balance, cognitive functions, movement and nonmovement PD symptoms, and BMI. We expect that our results will aid in the implementation of well-organized patient-centered and culturally tailored dance programs for patients with PD, thus providing reliable evidence for better recommendations for clinical practice.

Conclusions

The results of this study are expected to show the possible differential effect of a patient-centered and culturally tailored DfPD intervention, delivered in-person versus online, on several movement and nonmovement symptoms, as well as on QoL, sarcopenia, and frailty in people living with PD in Greece.

Acknowledgments

The authors would like to thank Prof Dimitrios Farmakis for his valuable academic guidance throughout the study, Georgios Xiros for providing the venue for conducting the farewell dance class, and the Greek Parkinson’s union, “ΠΑΡ.ΚΙΝ.Σ.Ο.Ν.” for their support in the study’s implementation. This project is partially funded by the charitable association World in Harmony/Mundo en Armonia (fiscal identification number G-78416047). The funder had no role in study design or in the collection, management, analysis, or interpretation of data.

Authors' Contributions

ME was responsible for conceptualization, visualization, methodology, investigation, data collection, project administration, and writing (original draft). IG was responsible for software, methodology, sample calculation, and data analysis. MP was responsible for methodology, validation, and writing (review). NP, AB, AMS, ES, I Alexandratou, I Alefanti, RA, CK, and IM were responsible for data collection. CC was responsible for data curation. LS was responsible for writing (review and editing), methodology, validation, and conceptualization. DB was responsible for conceptualization, validation, writing (review), and supervision.

Conflicts of Interest

None declared.

  1. Dos Santos Delabary M, Komeroski IG, Monteiro EP, Costa RR, Haas AN. Effects of dance practice on functional mobility, motor symptoms and quality of life in people with Parkinson's disease: a systematic review with meta-analysis. Aging Clin Exp Res. Jul 4, 2018;30(7):727-735. [CrossRef] [Medline]
  2. Ponsoni A, Sardeli AV, Costa FP, Mourão LF. Prevalence of sarcopenia in Parkinson's disease: a systematic review and meta-analysis. Geriatr Nurs. Jan 2023;49:44-49. [CrossRef] [Medline]
  3. Ahmed NN, Sherman SJ, Vanwyck D. Frailty in Parkinson's disease and its clinical implications. Parkinsonism Relat Disord. May 2008;14(4):334-337. [CrossRef] [Medline]
  4. Smith N, Brennan L, Gaunt DM, Ben-Shlomo Y, Henderson E. Frailty in Parkinson’s disease: a systematic review. J Parkinsons Dis. 2019;9(3):517-524. [FREE Full text] [CrossRef] [Medline]
  5. Johansson H, Hagströmer M, Grooten WJ, Franzén E. Exercise-induced neuroplasticity in Parkinson's disease: a metasynthesis of the literature. Neural Plast. 2020;2020:8961493. [FREE Full text] [CrossRef] [Medline]
  6. Smith TO, Jimoh OF, Cross J, Allan L, Corbett A, Sadler E, et al. Social prescribing programmes to prevent or delay frailty in community-dwelling older adults. Geriatrics (Basel). Nov 27, 2019;4(4):65. [FREE Full text] [CrossRef] [Medline]
  7. Monteiro EP, Franzoni LT, Cubillos DM, de Oliveira Fagundes A, Carvalho AR, Oliveira HB, et al. Effects of Nordic walking training on functional parameters in Parkinson's disease: a randomized controlled clinical trial. Scand J Med Sci Sports. Mar 02, 2017;27(3):351-358. [CrossRef] [Medline]
  8. Elpidoforou M. Types of dance: steps and positions. In: Angoules A, editor. Overuse Injuries in Dancers. Hyderabad, India. OMICS Group; 2016:1-9.
  9. Basso JC, Satyal MK, Rugh R. Dance on the brain: enhancing intra- and inter-brain synchrony. Front Hum Neurosci. Jan 7, 2020;14:584312. [FREE Full text] [CrossRef] [Medline]
  10. Lykesas G, Giotsios I, Douka S, Bakirtzoglou P. Epistemological assumptions about the relationship between quality of life and dance: a different approach. Sport Sci. 2019;12(1):77-82. [FREE Full text]
  11. García-Casares N, Martín-Colom JE, García-Arnés JA. Music therapy in Parkinson's disease. J Am Med Dir Assoc. Dec 2018;19(12):1054-1062. [CrossRef] [Medline]
  12. Baumeister RF, Leary MR. The need to belong: desire for interpersonal attachments as a fundamental human motivation. Psychol Bull. 1995;117(3):497-529. [CrossRef]
  13. Crumbie V, Olmos F, Watts C, Avery A, Nelson R. The impact of dance interventions on mood and depression in older adults. Ther Recreat J. 2015;49(2). [FREE Full text]
  14. Keogh JW, Kilding A, Pidgeon P, Ashley L, Gillis D. Physical benefits of dancing for healthy older adults: a review. J Aging Phys Act. Oct 2009;17(4):479-500. [CrossRef] [Medline]
  15. Hansen P, Main C, Hartling L. Dance intervention affects social connections and body appreciation among older adults in the long term despite COVID-19 social isolation: a mixed methods pilot study. Front Psychol. Feb 25, 2021;12:635938. [FREE Full text] [CrossRef] [Medline]
  16. Lima MM, Vieira AP. Ballroom dance as therapy for the elderly in Brazil. Am J Dance Ther. Sep 25, 2007;29(2):129-142. [CrossRef]
  17. McNeely ME, Duncan RP, Earhart GM. Impacts of dance on non-motor symptoms, participation, and quality of life in Parkinson disease and healthy older adults. Maturitas. Dec 2015;82(4):336-341. [FREE Full text] [CrossRef] [Medline]
  18. Alfredsson Olsson E, Heikkinen S. "I will never quit dancing". The emotional experiences of social dancing among older persons. J Aging Stud. Dec 2019;51:100786. [FREE Full text] [CrossRef] [Medline]
  19. Karpati FJ, Giacosa C, Foster NE, Penhune VB, Hyde KL. Dance and the brain: a review. Ann N Y Acad Sci. Mar 2015;1337:140-146. [CrossRef] [Medline]
  20. Bar A, Czamanski-Cohen J, Federman JD. I feel like I am flying and full of life: contemporary dance for Parkinson's patients. Front Psychol. Jul 5, 2021;12:623721. [FREE Full text] [CrossRef] [Medline]
  21. Hasan SM, Alshafie S, Hasabo EA, Saleh M, Elnaiem W, Qasem A, et al. Efficacy of dance for Parkinson's disease: a pooled analysis of 372 patients. J Neurol. Mar 08, 2022;269(3):1195-1208. [CrossRef] [Medline]
  22. Shanahan J, Morris ME, Bhriain ON, Volpe D, Lynch T, Clifford AM. Dancing for Parkinson disease: a randomized trial of Irish set dancing compared with usual care. Arch Phys Med Rehabil. Sep 2017;98(9):1744-1751. [CrossRef]
  23. Rocha P, Aguiar L, McClelland JA, Morris ME. Dance therapy for Parkinson's disease: a randomised feasibility trial. Int J Ther Rehab. Feb 02, 2018;25(2):64-72. [CrossRef]
  24. Wang LL, Sun CJ, Wang Y, Zhan TT, Yuan J, Niu CY, et al. Effects of dance therapy on non-motor symptoms in patients with Parkinson's disease: a systematic review and meta-analysis. Aging Clin Exp Res. Jun 29, 2022;34(6):1201-1208. [CrossRef] [Medline]
  25. Hackney ME, Earhart GM. Effects of dance on gait and balance in Parkinson's disease: a comparison of partnered and nonpartnered dance movement. Neurorehabil Neural Repair. May 14, 2010;24(4):384-392. [FREE Full text] [CrossRef] [Medline]
  26. Rocha PA, Slade SC, McClelland J, Morris ME. Dance is more than therapy: qualitative analysis on therapeutic dancing classes for Parkinson's. Complement Ther Med. Oct 2017;34:1-9. [CrossRef] [Medline]
  27. Emmanouilidis S, Hackney ME, Slade SC, Heng H, Jazayeri D, Morris ME. Dance is an accessible physical activity for people with Parkinson's disease. Parkinsons Dis. Oct 22, 2021;2021:7516504. [FREE Full text] [CrossRef] [Medline]
  28. Morris ME, Slade SC, Wittwer JE, Blackberry I, Haines S, Hackney ME, et al. Online dance therapy for people with Parkinson's disease: feasibility and impact on consumer engagement. Neurorehabil Neural Repair. Dec 2021;35(12):1076-1087. [CrossRef] [Medline]
  29. McRae C, Leventhal D, Westheimer O, Mastin T, Utley J, Russell D. Long-term effects of Dance for PD® on self-efficacy among persons with Parkinson’s disease. Arts Health. May 28, 2017;10(1):85-96. [CrossRef]
  30. Westheimer O, McRae C, Henchcliffe C, Fesharaki A, Glazman S, Ene H, et al. Dance for PD: a preliminary investigation of effects on motor function and quality of life among persons with Parkinson's disease (PD). J Neural Transm (Vienna). Sep 3, 2015;122(9):1263-1270. [CrossRef] [Medline]
  31. Heiberger L, Maurer C, Amtage F, Mendez-Balbuena I, Schulte-Mönting J, Hepp-Reymond MC, et al. Impact of a weekly dance class on the functional mobility and on the quality of life of individuals with Parkinson's disease. Front Aging Neurosci. 2011;3:14. [FREE Full text] [CrossRef] [Medline]
  32. McNeely ME, Mai MM, Duncan RP, Earhart GM. Differential effects of tango versus dance for PD in Parkinson disease. Front Aging Neurosci. Dec 21, 2015;7:239. [FREE Full text] [CrossRef] [Medline]
  33. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. Nov 27, 2013;310(20):2191-2194. [CrossRef] [Medline]
  34. Bandholm T, Christensen R, Thorborg K, Treweek S, Henriksen M. Preparing for what the reporting checklists will not tell you: the PREPARE Trial guide for planning clinical research to avoid research waste. Br J Sports Med. Oct 07, 2017;51(20):1494-1501. [CrossRef] [Medline]
  35. Dwan K, Li T, Altman DG, Elbourne D. CONSORT 2010 statement: extension to randomised crossover trials. BMJ. Jul 31, 2019;366:l4378. [FREE Full text] [CrossRef] [Medline]
  36. Chan AW, Tetzlaff JM, Altman DG, Dickersin K, Moher D. SPIRIT 2013: new guidance for content of clinical trial protocols. Lancet. Jan 12, 2013;381(9861):91-92. [CrossRef] [Medline]
  37. Chan A, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. Feb 05, 2013;158(3):200-207. [FREE Full text] [CrossRef] [Medline]
  38. Butcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, et al. Guidelines for reporting outcomes in trial protocols: the SPIRIT-outcomes 2022 extension. JAMA. Dec 20, 2022;328(23):2345-2356. [CrossRef] [Medline]
  39. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. May 1967;17(5):427-442. [CrossRef] [Medline]
  40. Volpe D, Signorini M, Marchetto A, Lynch T, Morris ME. A comparison of Irish set dancing and exercises for people with Parkinson's disease: a phase II feasibility study. BMC Geriatr. Jun 04, 2013;13(1):54. [FREE Full text] [CrossRef] [Medline]
  41. Verstraeten LM, van Wijngaarden JP, Kim DY, Meskers CG, Maier AB. Feasibility of bioelectrical impedance analysis in routine clinical care to assess body composition in geriatric rehabilitation inpatients: RESORT. Aging Clin Exp Res. Feb 07, 2023;35(2):293-302. [CrossRef] [Medline]
  42. Feeney MP, Xu Y, Surface M, Shah H, Vanegas-Arroyave N, Chan AK, et al. The impact of COVID-19 and social distancing on people with Parkinson's disease: a survey study. NPJ Parkinsons Dis. Jan 21, 2021;7(1):10. [FREE Full text] [CrossRef] [Medline]
  43. Mañago MM, Swink LA, Hager ER, Gisbert R, Earhart GM, Christiansen CL, et al. The impact of COVID-19 on community-based exercise classes for people with Parkinson disease. Phys Ther. Nov 01, 2021;101(11):pzab203. [FREE Full text] [CrossRef] [Medline]
  44. Massetti T, da Silva TD, Crocetta TB, Guarnieri R, de Freitas BL, Bianchi Lopes P, et al. The clinical utility of virtual reality in neurorehabilitation: a systematic review. J Cent Nerv Syst Dis. Nov 27, 2018;10:1179573518813541. [FREE Full text] [CrossRef] [Medline]
  45. Elpidoforou M, Bakalidou D, Drakopoulou M, Kavga A, Chrysovitsanou C, Stefanis L. Effects of a structured dance program in Parkinson's disease. A Greek pilot study. Complement Ther Clin Pract. Feb 2022;46:101528. [CrossRef] [Medline]
  46. Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL. The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis. Mov Disord. Apr 15, 2008;23(5):631-640. [CrossRef] [Medline]
  47. Keus SH, Bloem BR, Hendriks EJ, Bredero-Cohen AB, Munneke M, Practice Recommendations Development Group. Evidence-based analysis of physical therapy in Parkinson's disease with recommendations for practice and research. Mov Disord. Mar 15, 2007;22(4):451-60; quiz 600. [CrossRef] [Medline]
  48. Silva CM, Travessa AM, Bouça-Machado R, Caldeira D, Ferreira JJ. Reporting and methodological quality of clinical trials on exercise therapy for Parkinson's disease. Parkinsonism Relat Disord. Dec 2019;69:150-156. [CrossRef] [Medline]
  49. Hackney ME, Earhart GM. Health-related quality of life and alternative forms of exercise in Parkinson disease. Parkinsonism Relat Disord. Nov 2009;15(9):644-648. [FREE Full text] [CrossRef] [Medline]
  50. Hackney ME, Earhart GM. Effects of dance on movement control in Parkinson's disease: a comparison of Argentine tango and American ballroom. J Rehabil Med. May 2009;41(6):475-481. [FREE Full text] [CrossRef] [Medline]
  51. Synnott A. Tomb, temple, machine and self: the social construction of the body. Br J Sociol. Mar 1992;43(1):79. [CrossRef]
  52. Morus IR. The measure of man: technologizing the Victorian body. Hist Sci. Sep 21, 1999;37 Pt 3(117):249-282. [CrossRef] [Medline]
  53. Nicholls DA, Gibson BE. The body and physiotherapy. Physiother Theory Pract. Nov 26, 2010;26(8):497-509. [CrossRef] [Medline]
  54. Engel GL. The need for a new medical model: a challenge for biomedicine. Psychodyn Psychiatry. Sep 2012;40(3):377-396. [CrossRef] [Medline]
  55. Stewart M. Patient-Centered Medicine: Transforming the Clinical Method. Buckinghamshire, UK. Radcliffe Medical Press; 1995.
  56. Langendoen J. The patient-centredness of evidence-based practice. A case example to discuss the clinical application of the bio-psychosocial model. Manual Ther. Nov 2004;9(4):228-233. [CrossRef]
  57. Saxena A, Paredes-Echeverri S, Michaelis R, Popkirov S, Perez DL. Using the biopsychosocial model to guide patient-centered neurological treatments. Semin Neurol. Apr 03, 2022;42(2):80-87. [CrossRef] [Medline]
  58. van der Eijk M, Faber MJ, Al Shamma S, Munneke M, Bloem BR. Moving towards patient-centered healthcare for patients with Parkinson's disease. Parkinsonism Relat Disord. Jun 2011;17(5):360-364. [CrossRef] [Medline]
  59. Paul-Savoie E, Bourgault P, Potvin S, Gosselin E, Lafrenaye S. The impact of pain invisibility on patient-centered care and empathetic attitude in chronic pain management. Pain Res Manag. Sep 24, 2018;2018:6375713. [FREE Full text] [CrossRef] [Medline]
  60. Ramirez-Zamora A, Chana P, Rodríguez-Violante M. Editorial: patient empowerment and person-centered care in movement disorders. Front Neurol. Apr 28, 2020;11:317. [FREE Full text] [CrossRef] [Medline]
  61. Hansen LS, Præstegaard J, Lehn-Christiansen S. Patient-centeredness in physiotherapy - a literature mapping review. Physiother Theory Pract. Dec 07, 2022;38(12):1843-1856. [CrossRef] [Medline]
  62. Brown JB, Stewart M, Tessier S. Assessing communication between patients and physicians: a manual for scoring patient-centred communication. Western University Centre for Studies in Family Medicine. 1995. URL: https:/​/www.​schulich.uwo.ca/​familymedicine/​research/​csfm/​publications/​working_papers/​assessing_communication_between_patients_and_physicians_a_manual_for_scoring_patientcentred_communication.​html [accessed 2025-04-15]
  63. Little P, Everitt H, Williamson I, Warner G, Moore M, Gould C, et al. Preferences of patients for patient centred approach to consultation in primary care: observational study. BMJ. Feb 24, 2001;322(7284):468-472. [FREE Full text] [CrossRef] [Medline]
  64. Stewart M. Towards a global definition of patient centred care. BMJ. Feb 24, 2001;322(7284):444-445. [FREE Full text] [CrossRef] [Medline]
  65. Dukhu S, Purcell C, Bulley C. Person-centred care in the physiotherapeutic management of long-term conditions: a critical review of components, barriers and facilitators. Int Pract Dev J. Nov 15, 2018;8(2):1-27. [CrossRef]
  66. Gardikiotis A, Baltzis A. ‘Rock music for myself and justice to the world!’: musical identity, values, and music preferences. Psychol Music. Jan 14, 2011;40(2):143-163. [CrossRef]
  67. Westheimer O. Why dance for Parkinson’s disease. Top Geriatr Rehabil. 2007:1-13. [FREE Full text]
  68. Kalyani HH, Sullivan KA, Moyle G, Brauer S, Jeffrey ER, Kerr GK. Impacts of dance on cognition, psychological symptoms and quality of life in Parkinson's disease. NeuroRehabilitation. Nov 07, 2019;45(2):273-283. [CrossRef] [Medline]
  69. DeVereaux C, Griffin M. Narrative, Identity, and the Map of Cultural Policy: Once Upon a Time in a Globalized World. London, UK. Routledge; 2013.
  70. Reed S. The politics and poetics of dance. Annu Rev Anthropol. Oct 1998;27(1):503-532. [FREE Full text] [CrossRef]
  71. Meyer M. Dance and the politics of orality: a study of the Irish Scoil Rince. Dance Res J. Jul 22, 2014;27(1):25-39. [CrossRef]
  72. Shapiro T. The dancer in Cambodia. Asian Art Culture. 1995;8(1):8-23. [FREE Full text] [CrossRef]
  73. Cowan JK. Dance and the Body Politic in Northern Greece. Princeton, NJ. Princeton University Press; 1991.
  74. Kalogeropoulou S. Greek dance and everyday nationalism in contemporary Greece. Dance Res Aotearoa. Jul 03, 2013;1:55. [CrossRef]
  75. Harper P. Dance in a changing society. Afr Arts. 1967;1(1):10-13. [FREE Full text] [CrossRef]
  76. Kealiinohomoku J. An anthropologist looks at ballet as a form of ethnic dance. In: Cohen M, Copeland R, editors. What is Dance? Readings in Theory and Criticism. Oxford, UK. Oxford University Press; 1983.
  77. Kealiinohomoku JW. You dance what you wear, and you wear your cultural values. In: Cordwell JM, Schwarz RW, editors. The Fabrics of Culture. The Hague, Netherlands. De Gruyter Mouton; 1979:77-86.
  78. Pasick RJ, D'Onofrio CN, Otero-Sabogal R. Similarities and differences across cultures: questions to inform a third generation for health promotion research. Health Educ Q. Dec 01, 1996;23(1_suppl):S142-S161. [CrossRef]
  79. Resnicow K, Baranowski T, Ahluwalia JS, Braithwaite RL. Cultural sensitivity in public health: defined and demystified. Ethn Dis. 1999;9(1):10-21. [Medline]
  80. Douka S, Zilidou VI, Lilou O, Tsolaki M. Greek traditional dances: a way to support intellectual, psychological, and motor functions in senior citizens at risk of neurodegeneration. Front Aging Neurosci. Jan 25, 2019;11:6. [FREE Full text] [CrossRef] [Medline]
  81. Kaltsatou A, Kouidi E, Fountoulakis K, Sipka C, Theochari V, Kandylis D, et al. Effects of exercise training with traditional dancing on functional capacity and quality of life in patients with schizophrenia: a randomized controlled study. Clin Rehabil. Sep 18, 2015;29(9):882-891. [CrossRef] [Medline]
  82. Aslanides A. Semiotic approaches of the music language: from cultural identity to nation branding. In: Zantides E, editor. Semiotics and Visual Communication III: Cultures of Branding. Newcastle upon Tyne, UK. Cambridge Scholars Publishing; 2019:344-360.
  83. Saragatsis E, Vamvakidou I. The Bouzouki’s signifiers and significance through the Zeibekiko dance song: "Evdokia’s Zeibekiko". Eur Sci J. 2017;13(35):125. [CrossRef]
  84. Andreopoulos A. Imago poetae: the aesthetics of Manos Hadjidakis. J Modern Greek Stud. Oct 2001;19(2):255-268. [CrossRef]
  85. Orfanos SD. The creative boldness of Mikis Theodorakis. J Mod Hellenism. 1999;16. [FREE Full text]
  86. Pateraki M, Mountakis C. Zorba’s cinematic dance: global fame, local claim beyond studios and screens. Sci Dance. 2013;6:67-85.
  87. Makriyannakis V. The poetics of the ‘not yet’ in The Suspended Step of the Stork. Stud Eur Cinema. Sep 23, 2014;11(2):126-138. [CrossRef]
  88. Skopeteas I. Statistics and cultural context in Theo Angelopoulos’s camerawork: the case of the film eternity and a day. FILMICON J Greek Film Stud. Oct 2015;2015(3):65-86. [FREE Full text] [CrossRef]
  89. Wills D. Greece and Britain Since 1945. Newcastle upon Tyne, UK. Cambridge Scholars Publishing; 2010.
  90. Hargreaves DJ, Miell D, Macdonald RA. What are musical identities, and why are they important. In: MacDonald RA, Hargreaves DJ, Miell D, editors. Musical Identities. Oxford, UK. Oxford University Press; 2002.
  91. Tajfel H, Turner JC. An integrative theory of intergroup conflict. In: Austin WG, Worchel S, editors. The Social Psychology of Intergroup Relations. Monterey, CA. Brooks/Cole Publishing Company; 1979.
  92. Turner JC, Hogg MA, Oakes PJ, Reicher SD, Wetherell MS. Rediscovering the Social Group: A Self-Categorization Theory. Hoboken, NJ. Blackwell Publishing Ltd; 1987.
  93. Konstantinou A. Music preferences and music functions of University of Macedonia students. University of Macedonia. 2015. URL: https://dspace.lib.uom.gr/bitstream/2159/17496/3/KonstantinouAsterios_Pe2015.pdf [accessed 2025-04-15]
  94. Katsarou Z, Bostantjopoulou S, Peto V, Kafantari A, Apostolidou E, Peitsidou E. Assessing quality of life in Parkinson's disease: can a short-form questionnaire be useful? Mov Disord. Mar 20, 2004;19(3):308-312. [CrossRef] [Medline]
  95. Jenkinson C, Fitzpatrick R, Peto V, Dummett S, Morley D, Saunders P. The Parkinson’s Disease Questionnaires User Manual (PDQ-39, PDQ-8, PDQ Summary Index & PDQ-Carer). Oxford, UK. Oxford University Innovation Limited; 2012.
  96. Guidance for industry addendum to E2C clinical safety data management: periodic safety update reports for marketed drugs. U.S. Department of Health and Human Services, Food and Drug Administratio, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Feb 2004. URL: https://www.govinfo.gov/content/pkg/GOVPUB-HE20-PURL-LPS113936/pdf/GOVPUB-HE20-PURL-LPS113936.pdf [accessed 2025-04-10]
  97. Giladi N, Alcalay RN, Cutter G, Gasser T, Gurevich T, Höglinger GU, et al. Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. Aug 2023;22(8):661-671. [CrossRef]
  98. Fielding RA, Katula J, Miller ME, Abbott-Pillola K, Jordan A, Glynn NW, et al. Activity adherence and physical function in older adults with functional limitations. Med Sci Sports Exerc. Nov 2007;39(11):1997-2004. [CrossRef] [Medline]
  99. de Morton NA. The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study. Aust J Physiother. 2009;55(2):129-133. [CrossRef] [Medline]
  100. Blandy LM, Beevers WA, Fitzmaurice K, Morris ME. Therapeutic argentine tango dancing for people with mild Parkinson's disease: a feasibility study. Front Neurol. May 27, 2015;6:122. [FREE Full text] [CrossRef] [Medline]
  101. Dagklis IE, Tsantaki E, Kazis D, Theodoridou V, Papagiannopoulos S, Ntantos D, et al. The Parkinson fatigue scale: an evaluation of its validity and reliability in Greek Parkinson's disease patients. Neurol Sci. Apr 8, 2019;40(4):683-690. [CrossRef] [Medline]
  102. Brown RG, Dittner A, Findley L, Wessely SC. The Parkinson fatigue scale. Parkinsonism Relat Disord. Jan 2005;11(1):49-55. [CrossRef] [Medline]
  103. Bakalidou D, Voumvourakis K, Tsourti Z, Papageorgiou E, Poulios A, Giannopoulos S. Validity and reliability of the Greek version of the Modified Fatigue Impact Scale in multiple sclerosis patients. Int J Rehabil Res. Sep 2014;37(3):271-276. [CrossRef] [Medline]
  104. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Paralyzed Veterans of America. 1998. URL: https:/​/www.​scholars.northwestern.edu/​en/​publications/​fatigue-and-multiple-sclerosis-evidence-based-management-strategi-2 [accessed 2025-04-15]
  105. Schiehser DM, Ayers CR, Liu L, Lessig S, Song DS, Filoteo JV. Validation of the Modified Fatigue Impact Scale in Parkinson's disease. Parkinsonism Relat Disord. Mar 2013;19(3):335-338. [CrossRef] [Medline]
  106. Lyrakos GN, Arvaniti C, Smyrnioti M, Kostopanagiotou G. Translation and validation study of the depression anxiety stress scale in the Greek general population and in a psychiatric patient's sample. Eur Psychiatr. Apr 16, 2020;26(S2):1731. [CrossRef]
  107. Pezirkianidis C, Karakasidou E, Lakioti A, Stalikas A. Psychometric properties of the Depression, Anxiety, Stress Scales-21 (DASS-21) in a Greek sample. Psychology. 2018;9(15):2933-2950. [FREE Full text] [CrossRef]
  108. Lovibond SH, Lovibond PF. Manual for the Depression Anxiety Stress Scales. Sydney, Australia. Psychology Foundation of Australia; 1995.
  109. Johnson AR, Lawrence BJ, Corti EJ, Booth L, Gasson N, Thomas MG, et al. Suitability of the depression, anxiety, and stress scale in Parkinson's disease. J Parkinsons Dis. May 27, 2016;6(3):609-616. [FREE Full text] [CrossRef] [Medline]
  110. Tsekoura M, Billis E, Tsepis E, Lampropoulou S, Beaudart C, Bruyere O, et al. Cross-cultural adaptation and validation of the Greek Version of the SARC-F for evaluating sarcopenia in Greek older adults. J Musculoskelet Neuronal Interact. Dec 01, 2020;20(4):505-512. [FREE Full text] [Medline]
  111. Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. Aug 2013;14(8):531-532. [CrossRef] [Medline]
  112. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. Jan 01, 2019;48(1):16-31. [FREE Full text] [CrossRef] [Medline]
  113. da Luz MC, Pinho CP, Bezerra GK, da Conceição Chaves de Lemos M, da Silva Diniz A, Cabral PC. SARC-F and SARC-CalF in screening for sarcopenia in older adults with Parkinson's disease. Exp Gerontol. Feb 2021;144:111183. [CrossRef] [Medline]
  114. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. Mar 01, 2001;56(3):M146-M157. [CrossRef]
  115. Papathanasiou G, Georgoudis G, Papandreou M, Spyropoulos P, Georgakopoulos D, Kalfakakou V, et al. Reliability measures of the short International Physical Activity Questionnaire (IPAQ) in Greek young adults. Hellenic J Cardiol. 2009;50(4):283-294. [FREE Full text] [Medline]
  116. Lampropoulou S, Gizeli A, Kalivioti C, Billis E, Gedikoglou IA, Nowicky I. Cross cultural adaptation of berg balance scale in Greek for various balance impairments. J Phys Med Rehabil Disabil. 2016;2:011. [CrossRef]
  117. Berg KO, Wood-Dauphinee SL, Williams JI, Maki B. Measuring balance in the elderly: validation of an instrument. Can J Public Health. 1992;83 Suppl 2:S7-11. [Medline]
  118. Qutubuddin AA, Pegg PO, Cifu DX, Brown R, McNamee S, Carne W. Validating the Berg Balance Scale for patients with Parkinson's disease: a key to rehabilitation evaluation. Arch Phys Med Rehabil. Apr 2005;86(4):789-792. [CrossRef] [Medline]
  119. Konstantopoulos K, Vogazianos P, Doskas T. Normative data of the Montreal cognitive assessment in the Greek population and Parkinsonian dementia. Arch Clin Neuropsychol. May 17, 2016;31(3):246-253. [CrossRef] [Medline]
  120. Konstantopoulos K, Vogazianos P. Montreal Cognitive Assessment in a Greek sample of patients with multiple sclerosis: a validation study. Appl Neuropsychol Adult. Apr 02, 2021;28(1):48-52. [CrossRef] [Medline]
  121. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. Apr 2005;53(4):695-699. [CrossRef] [Medline]
  122. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. Nov 15, 2008;23(15):2129-2170. [CrossRef] [Medline]
  123. Durrer Schutz D, Busetto L, Dicker D, Farpour-Lambert N, Pryke R, Toplak H, et al. European practical and patient-centred guidelines for adult obesity management in primary care. Obes Facts. Jan 23, 2019;12(1):40-66. [FREE Full text] [CrossRef] [Medline]
  124. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York, New York. Routledge; 1988.
  125. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. May 2007;39(2):175-191. [CrossRef]
  126. Gupta KK, Attri JP, Singh A, Kaur H, Kaur G. Basic concepts for sample size calculation: critical step for any clinical trials! Saudi J Anaesth. 2016;10(3):328-331. [CrossRef]
  127. Efird J. Blocked randomization with randomly selected block sizes. Int J Environ Res Public Health. Jan 23, 2011;8(1):15-20. [FREE Full text] [CrossRef] [Medline]
  128. Sparrow D, DeMolles D, Dubaz O, Durso R, Rosner B. Design issues in crossover trials involving patients with Parkinson's disease. Front Neurol. Aug 21, 2023;14:1197281. [FREE Full text] [CrossRef] [Medline]
  129. Wiley RW, Rapp B. Statistical analysis in small-N designs: using linear mixed-effects modeling for evaluating intervention effectiveness. Aphasiology. Mar 21, 2019;33(1):1-30. [FREE Full text] [CrossRef] [Medline]
  130. Farmakis D, Thodi M, Elpidoforou M, Filippatos G. Assessing frailty in heart failure. Eur J Heart Fail. Nov 26, 2020;22(11):2134-2137. [FREE Full text] [CrossRef] [Medline]
  131. McMillan JM, Michalchuk Q, Goodarzi Z. Frailty in Parkinson's disease: a systematic review and meta-analysis. Clin Park Relat Disord. 2021;4:100095. [FREE Full text] [CrossRef] [Medline]


CONSORT: Consolidated Standards of Reporting Trials
DfPD: Dance for Parkinson’s Disease
PD: Parkinson disease
QoL: quality of life
UPGRADE-PD: Upbeating Greek Application of Dance in Parkinson’s Disease


Edited by A Schwartz, J Sarvestan; submitted 16.08.24; peer-reviewed by G Vasileios, J Hwang, M Petralito; comments to author 31.01.25; revised version received 23.02.25; accepted 26.03.25; published 02.05.25.

Copyright

©Michail Elpidoforou, Irene Grimani, Marianna Papadopoulou, Nikolaos Papagiannakis, Anastasia Bougea, Athina-Maria Simitsi, Evangelos Sfikas, Ioanna Alexandratou, Ioanna Alefanti, Roubina Antonelou, Christos Koros, Ioanna Mavroyianni, Chrysa Chrysovitsanou, Leonidas Stefanis, Daphne Bakalidou. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 02.05.2025.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.